BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31480625)

  • 41. Prediction of new chromene-based inhibitors of tubulin using structure-based virtual screening and molecular dynamics simulation methods.
    Aryapour H; Dehdab M; Sohraby F; Bargahi A
    Comput Biol Chem; 2017 Dec; 71():89-97. PubMed ID: 28992456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel chemotypes targeting tubulin at the colchicine binding site and unbiasing P-glycoprotein.
    Mangiatordi GF; Trisciuzzi D; Alberga D; Denora N; Iacobazzi RM; Gadaleta D; Catto M; Nicolotti O
    Eur J Med Chem; 2017 Oct; 139():792-803. PubMed ID: 28863359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization Inhibitors.
    Rawal R; Gupta PK; Kumar B; Bhatia R
    Assay Drug Dev Technol; 2023 Jan; 21(1):17-28. PubMed ID: 36594970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4]triazoles as potent tubulin polymerization inhibitors.
    Li N; Guan Q; Hong Y; Zhang B; Li M; Li X; Li B; Wu L; Zhang W
    Eur J Med Chem; 2023 Aug; 256():115402. PubMed ID: 37182330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Lin S; Du T; Zhang J; Wu D; Tian H; Zhang K; Jiang L; Lu D; Sheng L; Li Y; Ji M; Chen X; Xu H
    J Med Chem; 2022 Dec; 65(24):16372-16391. PubMed ID: 36511661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of novel and potent small-molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations.
    Liu G; Jiao Y; Huang C; Chang P
    J Comput Aided Mol Des; 2019 Jul; 33(7):659-664. PubMed ID: 31165955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
    Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
    Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
    Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
    Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
    Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.
    Ren Y; Ruan Y; Cheng B; Li L; Liu J; Fang Y; Chen J
    Bioorg Med Chem; 2021 Sep; 46():116376. PubMed ID: 34455231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and biological evaluation of diaryl heterocyclic derivatives targeting tubulin polymerization with potent anticancer activities.
    Li G; Wu JQ; Cai X; Guan W; Zeng Z; Ou Y; Wu X; Li J; Fang X; Liu J; Zhang Y; Wang H; Yin C; Yao H
    Eur J Med Chem; 2023 Apr; 252():115284. PubMed ID: 36940610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tubulin inhibitor identification by bioactive conformation alignment pharmacophore-guided virtual screening.
    Nagarajan S; Choi MJ; Cho YS; Min SJ; Keum G; Kim SJ; Lee CS; Pae AN
    Chem Biol Drug Des; 2015 Nov; 86(5):998-1016. PubMed ID: 25845798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors.
    Kode J; Kovvuri J; Nagaraju B; Jadhav S; Barkume M; Sen S; Kasinathan NK; Chaudhari P; Mohanty BS; Gour J; Sigalapalli DK; Ganesh Kumar C; Pradhan T; Banerjee M; Kamal A
    Bioorg Chem; 2020 Dec; 105():104447. PubMed ID: 33207276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of Novel
    Leng J; Zhao Y; Sheng P; Xia Y; Chen T; Zhao S; Xie S; Yan X; Wang X; Yin Y; Kong L
    J Med Chem; 2022 Dec; 65(24):16774-16800. PubMed ID: 36471625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization.
    Zhang R; Mo H; Ma YY; Zhao DG; Zhang K; Zhang T; Chen X; Zheng X
    Bioorg Med Chem Lett; 2021 May; 40():127968. PubMed ID: 33753264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
    Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
    Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.